Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
about
Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective studyBRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.Salvage treatment of relapsed/refractory LCHNew somatic BRAF splicing mutation in Langerhans cell histiocytosis.Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis.
P2860
Q33717259-D3C071C6-E680-4064-9AB9-1ED112DC45EFQ37659076-C3E77A4C-D764-451E-9AC4-D24D277DF254Q38602233-DD2F8660-5000-43B2-9212-C7ACC34AD1F0Q40464058-D6DFB5CB-F7C0-4400-8AD7-74A044EBBC09Q42195584-90A0D67E-D957-470B-AC06-807B3440C60BQ42331849-CB5DCFD6-159B-40C3-A573-1470CB0D4769Q53840508-EBCE5673-2810-4593-920F-26E48164C1FB
P2860
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Langerhans cell histiocytosis: ...... atients under 18 years of age.
@en
type
label
Langerhans cell histiocytosis: ...... atients under 18 years of age.
@en
prefLabel
Langerhans cell histiocytosis: ...... atients under 18 years of age.
@en
P2093
P2860
P50
P356
P1476
Langerhans cell histiocytosis: ...... patients under 18 years of age
@en
P2093
Abdellatif Tazi
Anne Deville
Anne Lambilliotte
Aurore Coulomb
Caroline Thomas
Charlotte Rigaud
Claire Galambrun
Corinne Armari-Alla
Eric Jeziorski
Geneviève Plat
P2860
P304
P356
10.1111/BJH.14140
P407
P577
2016-06-07T00:00:00Z